Recent Finacing
Recent Raise
Spinout from PARI Pharmaceuticals developing an inhaled drug-device combination—an inhalation formulation paired with a delivery device—for a rare lung disease, advancing into Phase III clinical trials.
Focus Areas
Total Raised
Funding round